Nektar Therapeutics NKTR

$43.58 -3.41 (-7.26%)

Valuation

Market cap
1,604,380,000
Revenue TTM
$55,230,000
Net income TTM
$-164,080,000
PE ratio
0.00
Forward PE
—
Profit margin
-297.08%
Debt to equity
0.00

Trading

Volume
2,923,400
Avg volume
1,084,364
Day's range
$43.51 – $47.13
Shares out
34,143,000
Stochastic %K
0%
Beta
1.26
Analysts
Strong Sell
Price target
$135.54

Price

Company profile

Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in the field of immunotherapy in the United States and internationally. It develops rezpegaldesleukin, which is in Phase 2b to treat underlying immune system imbalance in people with autoimmune disorders and inflammatory diseases; NKTR-0165 to treat ulcerative colitis, vitiligo, and multiple sclerosis; NKTR-0166 to treat...

Show more

Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in the field of immunotherapy in the United States and internationally. It develops rezpegaldesleukin, which is in Phase 2b to treat underlying immune system imbalance in people with autoimmune disorders and inflammatory diseases; NKTR-0165 to treat ulcerative colitis, vitiligo, and multiple sclerosis; NKTR-0166 to treat autoimmune disease; NKTR-422 to treat fibrotic diseases; and NKTR-255 to treat solid tumors and large b-cell lymphoma. It has collaboration agreements with Takeda Pharmaceutical Company Ltd.; AstraZeneca AB; UCB Pharma; F. Hoffmann-La Roche Ltd; Bausch Health Companies Inc.; Pfizer Inc.; UCB Pharma (Biogen); Bristol-Myers Squibb Company; and Merck KGaA. The company was incorporated in 1990 and is headquartered in San Francisco, California.

Industry
Biotechnology
Sector
Healthcare
Phone
415 482 5300
Website
https://www.nektar.com
Address
455 Mission Bay Boulevard South, San Francisco, United States

Latest news

Stocktwits

BK217 Oct 3, 12:32 PM
$NKTR omfg when will he bottom???
0 replies
ShortNKTR Oct 2, 8:24 PM
$NKTR so bad. this one is g to 25
0 replies
autographic Oct 2, 6:47 PM
$NKTR stacking bids starting but needs some help with vol- if that vwap 45 challenge breaks to the upside - panic re buying 😂
0 replies
Tipcadog Oct 2, 6:29 PM
$NKTR this is a great opportunity for those who bought late. this will go back up to $140 and up. hold your position buy but don’t sell. this is Gold. too good of a product.
1 replies
CH_Expat Oct 2, 6:23 PM
$NKTR One for the Bionervewrecking Hall of Fame without a doubt. Respect if you are long here for years.
0 replies
Tipcadog Oct 2, 6:17 PM
$NKTR keep buying it up, could wait until it bottoms out some more but at any rate don’t sell. it will go up in a matter of time. too good of a product. Promise
0 replies
autographic Oct 2, 6:14 PM
$NKTR 🚨-Entered !
0 replies
Tipcadog Oct 2, 5:47 PM
$NKTR
0 replies